SYK Stryker Corp

   By Kimberly Chin 
 

Stryker Corp. lowered its adjusted earnings outlook for the year, citing uncertainty over the Covid-19 pandemic and challenges with labor and staffing in the healthcare industry "hindering an accelerated recovery."

The medical technology company now expects adjusted earnings between $9.08 and $9.15 a share, compared with its previous forecast of $9.25 to $9.40 a share. This includes any expenses associated with its Wright Medical Group NV acquisition.

The company expects net sales to increase organically by about 7% to 8% for the year compared with 2019, before the onset of the pandemic. It had previously forecast sales growth in the range of 9% to 10% versus 2019.

Stryker's shares slid 3.9% after hours to $258.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

October 28, 2021 17:03 ET (21:03 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.